Figma FIG Crushes Q4 2025 Estimates EPS 008 Tops Views Gloo Holdings GLOO Surges 200 Nearing 642 Resistance 20260518 Sangamo Therapeutics Draws Renewed Investor Attention Amid Biotech Sector Interest Insteel Industries IIIN Down 396 How Low Could It Go 20260517 TechEnabled Precision How Digital Tools Are Reshaping the Woodworking Industry EasyJet Reports Summer Booking Decline Amid Middle East Tensions and Rising Fuel Costs Pagaya Technologies PGY Faces Resistance After Recent Pullback IT Rally Likely a Dead Cat Bounce Ferrous Metals and Defence Sectors Show Promise Nischal Maheshwari Cricket Fandom Goes Digital Fan Tokens Could Be the Next Big Play in Sports Engagement BioPrime Partners with Mosaic to Integrate Biological Solutions for Sustainable Agriculture Anthropics Surprise Profit Projection Signals Competitive Edge Ahead of Potential IPO Trump Urges Supreme Court to Halt TikTok Ban What It Means for Investors Spanish Stocks Edge Higher as IBEX 35 Closes Up 049 Amazon UK Boss Says Education System Failing Young Workers Calls for Shift in Blame FVCBankcorp Inc Q1 2026 Earnings EPS Beats Estimates by 4 Amid Challenging Banking Landscape TNXP Q1 2026 Earnings WiderthanExpected Loss Amid Continued RD Investment Mannatech Q3 2023 Earnings Modest Profitability Amid Limited Disclosures ELE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Sunrun RUN Q1 2026 Earnings Solar Leader Posts Record EPS Surprise Shares Rally CODA Q1 2026 Earnings EPS Beats Estimates by 2658 as Company Maintains Profitability Enpro Inc NPO Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Gain IQ Q1 2026 Earnings EPS Miss Weighs on Shares as iQIYI Navigates Challenging Landscape Inuvo Inc INUV Q1 2026 Earnings Massive EPS Beat Erases Loss Expectations Braemar Hotels Resorts Inc BHR Q1 2026 Earnings Massive EPS Surprise of 42178 Beats Estimates DERM Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Shares Decline Companies Remain Committed to Prediction Markets Amid Regulatory Uncertainty Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus